Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

BHST vs KGEI: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

KGEI Wins Head-to-Head Institutional Verdict (4–1 across 6 Pillars · 9–1 Matrix Metrics)

KGEI Overall Winner 6-Pillar Tally: BHST 1 – 4 KGEI (1 Tie) Matrix Metrics: BHST 1 – 9 KGEI

As of Nov 20, 2026, Kolibri Global Energy Inc. (KGEI) is the stronger overall head-to-head candidate over BioHarvest Sciences Inc. (BHST) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). BHST carries a Unified Composite Score of 58.2/100 (HOLD) at $1.30 (N/M Forward P/E, -18.0% operating margin), whereas KGEI carries 49.0/100 (HOLD) at $4.47 (5.3x Forward P/E, 39.8% operating margin).

  • Composite vs. Pillar Nuance: While BHST currently prints a higher short-term Unified Composite Score (58.2/100 HOLD vs. KGEI 49.0/100 HOLD), KGEI captures the overall institutional head-to-head verdict (9–1 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (39.8% vs. -18.0% operating margin) and revenue trajectory (+20.9% vs. +3.8% YoY).
  • Technical & Structure Timing Caution: BHST is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.2); meanwhile KGEI is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BHST vs KGEI
BHST NASDAQ
BioHarvest Sciences Inc. Common Stock
Pharmaceutical Preparations
$1.30
-1.52% 1D
Market Cap $29.9M
TTM Revenue $35M
Forward P/E N/M
Beta / 30D Vol 0.25β · 86% Vol
Unified Composite Score
58.2 / 100 HOLD
Tech 75.0 Fund 57.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -9.1%), weak momentum, RSI 37
RSI-14: 37.2 · SMA20: $1.55 · SMA50: $1.58
KGEI NASDAQ Head-to-Head Winner
Kolibri Global Energy Inc. Common Stock
Crude Petroleum & Natural Gas
$4.47
-3.14% 1D
Market Cap $166.1M
TTM Revenue $75M
Forward P/E 5.3x
Beta / 30D Vol -0.73β · 64% Vol
Unified Composite Score
49.0 / 100 HOLD
Tech 45.0 Fund 50.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -2.2%), weak momentum, RSI 25
RSI-14: 24.6 · SMA20: $5.78 · SMA50: $6.26

6-Pillar Scorecard Institutional Category Breakdown (BHST 1 – 4 KGEI)

Columns: Metric · BHST · KGEI
1. Valuation Multiples KGEI
Forward P/E N/M 5.3x
Trailing P/E N/M 8.6x
PEG Ratio N/M 0.58x
EV / Revenue 0.7x 2.2x
2. Growth & Scale KGEI
Revenue Growth (YoY) +3.8% +20.9%
Earnings Growth (YoY) +0.0% -0.6%
TTM Revenue (USD) $35M $75M
Market Cap $29.9M $166.1M
3. Profitability & Quality KGEI
Gross Margin 59.0% 84.5%
Operating Margin -18.0% 39.8%
Net Profit Margin -31.2% 25.7%
Return on Equity (ROE) -142.5% 9.1%
4. Balance Sheet & Cash Flow KGEI
Cash Generation (TTM) -$9.4M $47M EBITDA
Cash Flow Margin -26.6% 62.4% EBITDA Mgn
Net Cash / Leverage $5.1M Net Cash $6.19 Book/Sh · 9.1% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat BHST
OpEx & R&D Intensity 77.0% of Rev ($27M) 44.7% of Rev ($34M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning High-Margin Pricing Power Moat
Supply-Chain Role Packaged Foods Operator Oil & Gas E&P Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BHST (1) vs KGEI (9)
Institutional Metric BHST KGEI Criterion Row Edge
Market Capitalization
Scale
$29.9M $166.1M Larger Scale KGEI
Trailing P/E Ratio
Valuation
N/M 8.6x Lower Multiple KGEI
Forward P/E Ratio
Valuation
N/M 5.3x Lower Multiple KGEI
Revenue Growth (YoY)
Growth
+3.8% +20.9% Higher Growth KGEI
Operating Margin (TTM)
Profitability
-18.0% 39.8% Higher Margin KGEI
Net Profit Margin
Profitability
-31.2% 25.7% Higher Margin KGEI
Return on Equity (ROE)
Capital Efficiency
-142.5% 9.1% Higher ROE KGEI
52-Week Range Position
Momentum
6% ($1–$7) 28% ($3–$7) Stronger Trend KGEI
Beta / 30D Volatility
Risk Regime
0.25β · 86% Vol -0.73β · 64% Vol Lower Realized Risk KGEI
Unified Institutional Score
Composite Signal
58.2 / 100 (HOLD) 49.0 / 100 (HOLD) Higher Composite BHST
Trailing 12M Revenue (USD)
Operating Scale
$35M $75M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
59.0% 84.5% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.7x EV/Rev 0.58x PEG · 2.2x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$9.4M ($5.1M Net Cash) $47M EBITDA ($6.19 Book/Sh · 9.1% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon BHST +12.62 pp
BHST: -22.62% · KGEI: -35.24%
3M Horizon KGEI +11.42 pp
BHST: -36.59% · KGEI: -25.17%
6M Horizon KGEI +42.56 pp
BHST: -66.32% · KGEI: -23.76%
1Y Horizon KGEI +91.0 pp
BHST: -79.4% · KGEI: +11.6%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BHST vs KGEI. Trailing 12-month operating profitability (BHST -18.0% vs KGEI 39.8%) and valuation multiples (BHST N/M vs KGEI 5.3x Forward P/E) are benchmarked directly in Pillar 4 below.

BHST ADR TTM Benchmark FX-Normalized USD
TTM Revenue$35M
Gross Margin59.0%
Op. Margin-18.0%
ROE / Fwd P/E-142.5% · N/M
KGEI ADR TTM Benchmark FX-Normalized USD
TTM Revenue$75M
Gross Margin84.5%
Op. Margin39.8%
ROE / Fwd P/E9.1% · 5.3x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BHST UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BHST Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
KGEI UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact KGEI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BHST Moat Profile Cyclical / Execution-Driven Positioning
Packaged Foods Operator
Competes within the Packaged Foods value chain with $29.9M market capitalization and -18.0% operating margin.
OpEx & R&D Reinvestment 77.0% of Rev ($27M)
90D Engineering Disclosures 0 Published
KGEI Moat Profile High-Margin Pricing Power Moat
Oil & Gas E&P Operator
Competes within the Oil & Gas E&P value chain with $166.1M market capitalization and 39.8% operating margin.
OpEx & R&D Reinvestment 44.7% of Rev ($34M)
90D Engineering Disclosures 0 Published

Investor FAQ BHST vs KGEI Key Questions & Quantitative Answers

As of Nov 20, 2026, Kolibri Global Energy Inc. (KGEI) is the stronger overall head-to-head candidate over BioHarvest Sciences Inc. (BHST) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). BHST carries a Unified Composite Score of 58.2/100 (HOLD) at $1.30 (N/M Forward P/E, -18.0% operating margin), whereas KGEI carries 49.0/100 (HOLD) at $4.47 (5.3x Forward P/E, 39.8% operating margin). Composite vs. Pillar Nuance: While BHST currently prints a higher short-term Unified Composite Score (58.2/100 HOLD vs. KGEI 49.0/100 HOLD), KGEI captures the overall institutional head-to-head verdict (9–1 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (39.8% vs. -18.0% operating margin) and revenue trajectory (+20.9% vs. +3.8% YoY). Technical & Structure Timing Caution: BHST is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.2); meanwhile KGEI is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

KGEI leads the Growth & Scale pillar: BHST posts +3.8% YoY revenue growth and +0.0% YoY earnings growth on $35M TTM revenue (59.0% gross margin, -18.0% operating margin), compared with KGEI at +20.9% YoY revenue growth and -0.6% YoY earnings growth on $75M TTM revenue (84.5% gross margin, 39.8% operating margin). On trailing 12-month operating scale, BHST generates $35M in USD-normalized revenue versus $75M for KGEI. In operating R&D and SG&A reinvestment, BHST deploys 77.0% of Rev ($27M) (0 90-day corporate R&D disclosures) versus 44.7% of Rev ($34M) (0 disclosures) for KGEI.

KGEI screens cheaper on headline valuation multiples. BHST trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.7x EV/Revenue (-26.6% FCF margin), whereas KGEI trades at 5.3x Forward P/E, 8.6x Trailing P/E, 0.58x PEG, and 2.2x EV/Revenue (62.4% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BHST (-142.5% ROE) versus KGEI (9.1% ROE) capital efficiency.

In options market volatility and institutional positioning, BHST carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.25β · 86% Vol realized risk). By comparison, KGEI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.73β · 64% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.